uce
ProgressImage ProgressImage
Biocon Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 532523 border-img ISIN Demat INE376G01013 border-img Book Value 90.38 border-img NSE Symbol BIOCON border-img Div & Yield % 0.49 border-img Market Cap ( Cr.) 36858.42 border-img P/E 0 border-img EPS 0.4 border-img Face Value 5
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales562.80518.70513.20
Other Operating Income0.000.000.00
Other Income 48.5069.6055.70
Total Income611.30588.30568.90
Total Expenditure 491.50456.70441.20
PBIDT119.80131.60127.70
Interest 56.0055.0048.30
PBDT63.8076.6079.40
Depreciation30.9030.6029.80
Tax12.308.203.90
Fringe Benefit Tax0.000.000.00
Deferred Tax-3.403.10-0.90
Reported Profit After Tax24.0034.7046.60
Extra-ordinary Items 0.00-3.9218.15
Adjusted Profit After Extra-ordinary item24.0038.6228.45
    
EPS (Unit Curr.)0.200.290.39
EPS (Adj) (Unit Curr.)0.200.290.39
Calculated EPS (Unit Curr.)0.200.290.39
Calculated EPS (Adj) (Unit Curr.)0.200.290.39
Calculated EPS (Ann.) (Unit Curr.)0.801.161.55
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.801.161.55
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity600.30600.30600.30
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)21.2925.3724.88
PBDTM(%)11.3414.7715.47
PATM(%)4.266.699.08
x
x
×
Let's Chat
close
refresh